Therapy of Human African Trypanosomiasis: Current Situation

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue 2, 1999, Pages 221-224

  Atouguia, Jorge ^a   Costa, José ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

Drugs; Human African trypanosomiasis; Review; Treatment

Indexed keywords

ANTITRYPANOSOMAL AGENT;

AFRICAN TRYPANOSOMIASIS; ANIMAL; HUMAN; REVIEW;

ANIMALS; HUMANS; TRYPANOCIDAL AGENTS; TRYPANOSOMIASIS, AFRICAN;

EID: 0033090473     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761999000200018     Document Type: Article

References (24)

1. Arroz J, Djedje M 1988. Suramin and metronidazole in the treatment of Trypanosoma brucei rhodesiense. Trans R Soc Trop Med Hyg 82: 421.
2. Atouguia JM, Jennings FW, Murray M 1995. Successful treatment of experimental murine Trypanosoma brucei infection with topical melarsoprol gel. Trans R Soc Trop Med Hyg 89: 531-533.
3. Burri C, Brun R 1992. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid. Trop Med Parasitol 43: 223-225.
4. Burri C, Baltz T, Giroud C, Doua F, Welker HA, Brun R 1993. Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy 39: 225-234.
5. Burri C, Blum J, Brun R 1995. Alternative application of melarsoprol for treatment of T. b. gambiense sleeping sickness. Ann Soc Belg Med Trop 65: 65-71.
6. Doua F, Boa Yapo F 1994. Actualités thérapeutiques de la trypanosomiase. Bull Soc Pathol Exotique 87: 337-340.
7. Enanga B, Labat C, Boudra H, Chauvière G, Keita M, Bouteille B, Dumas M, Houin G 1997. Simple high-preformance liquid chromatographic method to analyse megazol in human and rat plasma. J Chromatogr B Biomed Appl 696: 261-266.
8. Fairlamb AH 1990. Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis. Trans R Soc Trop Med Hyg 84: 613-611.
9. Foulkes JR 1996. Metronidazole and suramin combination in the treatment of arsenical refractory rhodesian sleeping sickness - a case study. Trans R Soc Trop Med Hyg 90: 422.
10. Ginoux PY, Bissadidi N, Frezil JL 1984. Accidents observés lors du traitement de la tripanosomiase au Congo. Med Trop 44: 351-355.
11. Heby O, Luk GD, Schindler J 1987. Polyamine synthesis inhibitors act as both inducers and suppressors of cell differentiation, p. 165-186. In PP McCann, AE Pegg, A Sjoerdsma (eds), Inhibition of Polyamine Metabolism, Academic Press, New York.
12. Janssens PG, De Muynck A 1977. Clinical trials with "Nifurtimox" in African trypanosomiasis. Ann Soc Belg Med Trop 57: 475-479.
13. Jennings FW, Atouguia JM, Murray M 1996. Topical chemotherapy for experimental murine African CNS-trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5-nitroimidazoles, fexinidazole or MK-436. Trop Med Int Health 5: 590-598.
14. Khonde N, Pépin J, Mpia B 1997. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness. Trans R Soc Trop Med Hyg 91: 212-213.
15. Maes L, Songa EB, Hamers R 1993. Imol 881, a new trypanocidal compound. Acta Trop 3-4: 261-269.
16. Moens F, De Wilde M, Kola Ngato 1984. Essai de traitment au nifurtimox de la trypanosomiase humaine africaine. Ann Soc Belg Med Trop 64: 37-43.
17. Schechter PJ, Barlow JLR, Sjoerdsma A 1987. Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases, p. 345-364. In PP McCann, AE Pegg, A Sjoerdsma (eds), Inhibition of Polyamine Metabolism, Academic Press, New York.
18. Simarro PP, Asumu PN 1996. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report. Trans R Soc Trop Med Hyg 90: 315.
19. Sunkara PS, Baylin SB, Luk GD 1987. Inhibition of polyamine biosynthesis: cellular and in vivo effects on tumor proliferation, p. 121-140. In PP McCann, AE Pegg, A Sjoerdsma (eds), Inhibition of Polyamine Metabolism, Academic Press, New York.
20. Taelman H, Clerinx J, Bogaerts J, Vervoort T 1996. Combination treatment with suramin and eflornithine in late stage rhodesian trypanosomiasis: case report. Trans R Soc Trop Med Hyg 90: 572-573.
21. Van Nieuwenhove S 1992. Advances in sleeping sickness therapy. Ann Soc Belg Med Trop 72: 39-51.
22. Van Nieuwenhove S, Schechter PJ, Declercq J, Boné G, Burke J, Sjoerdsma A 1985. Treatment of Gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxilase; first field trial. Trans R Soc Trop Med Hyg 79: 692-698.
23. WHO 1986. Epidemiology and control of African trypanosomiasis. Report of a WHO Expert Committee, Technical Report Series, World Health Organization, Geneva.
24. WHO 1995. Tropical Diseases Research. Progress 1975-94, Highlights 1993-1994. Twelfth Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva.